Tekafalin sodium (Zhaoke Pharmaceutical (Guangzhou)/Haimen Wisdom Pharmaceutical)

N/A

Report date: 2025/01/26 15:18:33
NME

Base Information

Drug NameTekafalin sodium (Zhaoke Pharmaceutical (Guangzhou)/Haimen Wisdom Pharmaceutical)
Drug Alias Namethromboembolism Small molecule therapeutic (Zhaoke Pharmaceutical (Guangzhou)/Haimen Wisdom Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhaoke Pharmaceutical (Guangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWisdom Pharmaceutical Co LtdZhaoke Pharmaceutical (Guangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A